Knockdown of NBCe1 in vivo compromises the corneal endothelial pump

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 10, 2010, Pages 5190-5197

  Liu, Cailing ^a   Cheng, Qiang ^a   Nguyen, Tracy ^a   Bonanno, Joseph A ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE SODIUM COTRANSPORTER; BRINZOLAMIDE; CARBONATE DEHYDRATASE; NBCE1 PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; BICARBONATE; CARBONATE DEHYDRATASE INHIBITOR; CARRIER PROTEIN; GREEN FLUORESCENT PROTEIN; SULFONAMIDE; THIAZINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR CHAMBER INFLAMMATION; ANTERIOR EYE CHAMBER; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CORNEA EDEMA; CORNEA ENDOTHELIUM; CORNEA THICKNESS; IMMUNOFLUORESCENCE; INFLAMMATION; INTRAOCULAR PRESSURE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RABBIT; RNA INTERFERENCE; WESTERN BLOTTING; ACTIVE TRANSPORT; ANIMAL; DRUG EFFECT; FELINE IMMUNODEFICIENCY VIRUS; FLUORESCENCE MICROSCOPY; GENE SILENCING; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BICARBONATES; BIOLOGICAL TRANSPORT, ACTIVE; BLOTTING, WESTERN; CARBONIC ANHYDRASE INHIBITORS; CARBONIC ANHYDRASES; ENDOTHELIUM, CORNEAL; GENE KNOCKDOWN TECHNIQUES; GENE SILENCING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; IMMUNODEFICIENCY VIRUS, FELINE; INTRAOCULAR PRESSURE; MEMBRANE TRANSPORT PROTEINS; MICROSCOPY, FLUORESCENCE; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SODIUM-BICARBONATE SYMPORTERS; SULFONAMIDES; THIAZINES; TRANSFECTION;

EID: 77958142894     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5257     Document Type: Article

References (50)

1. Baum J, Maurice D, McCarey B. The active and passive transport of water across the corneal endothelium. Exp Eye Res. 1984;39:335-342.
2. Maurice D. The location of the fluid pump in the cornea. J Physiol. 1972;221:43-54.
3. Riley MV, Winkler BS, Peters MI, Czajkowski CA. Relationship between fluid transport and in situ inhibition of Na(+)-K+ adenosine triphosphatase in corneal endothelium. Invest Ophthalmol Vis Sci. 1994;35:560-567.
4. Anderson EI, Fischbarg J. Biphasic effects of insulin and ouabain on fluid transport across rabbit corneal endothelium. J Physiol. 1978; 275:377-389.
5. Wingham CG, Guggenheim JA, Hodson SA. Sodium movement into and out of corneal encothelium. Eur J Physiol. 1994;428:577-582.
6. Hodson S, Miller F. The bicarbonate ion pump in the endothelium which regulates the hydration of rabbit cornea. J Physiol. 1976; 263:563-577.
7. Fischbarg J, Lim J. Role of cations, anions, and carbonic anhydrase in fluid transport across rabbit corneal endothelium. J Physiol. 1974;241:647-675.
8. Riley M, Winkler B, Czajkowski C, Peters M. The roles of bicarbonate and CO2 in transendothelial fluid movement and control of corneal thickness. Invest Ophthalmol Vis Sci. 1995;36:103-112.
9. Narula P, Xu M, Kuang K, Akiyama R, Fischbarg J. Fluid transport across cultured bovine corneal endothelial cell monolayers. Am J Physiol. 1992;262:C98-103.
10. Kuang K, Xu M, Koniarek J, Fischbarg J. Effects of ambient bicarbonate, phosphate and carbonic anhydrase inhibitors on fluid transport across rabbit endothelium. Exp Eye Res. 1990;50:487-493.
11. -exchange. Invest Ophthalmol Vis Sci. 1992;33: 3068-3079.
12. -. Invest Ophthalmol Vis Sci. 1992;33:3058-3067.
13. Sun XC, Bonanno JA. Identification and cloning of the Na/HCO(3-) cotransporter (NBC) in human corneal endothelium. Exp Eye Res. 2003;77:287-295.
14. - fluxes in bovine corneal endothelium. Am J Physiol Cell Physiol. 2005;288: C739-C746.
15. Liebovitch L, Fischbarg J. Effects of inhibitors of passive Na+ and HCO3 fluxes on electrical potential and fluid transport across rabbit corneal endothelium. Curr Eye Res. 1982;2:183-186.
16. Bonanno JA. Identity and regulation of ion transport mechanisms in the corneal endothelium. Prog Retin Eye Res. 2003;22:69-94.
17. - transport. Invest Ophthalmol Vis Sci. 2008;49:1048-1055.
18. Cui W, Liu G, Liang R. Expression of carbonic anhydrase IV in rabbit corneal endothelial cells. Chin Med J (Engl). 2002;115: 1641-1644.
19. Gottsch JD, Seitzman GD, Margulies EH, et al. Gene expression in donor corneal endothelium. Arch Ophthalmol. 2003;121:252-258.
20. Holthofer H, Siegal GJ, Tarkkanen A, Tervo T. Immunocytochemical localization of carbonic anhydrase, NaK-ATPase and the bicarbonate chloride exchanger in the anterior segment of the human eye. Acta Ophthalmol. 1991;69:149-154.
21. Bonanno JA, Srinivas SP, Brown M. Effect of acetazolamide on intracellular pH and bicarbonate transport on bovine corneal endothelium. Exp Eye Res. 1995;60:425-434.
22. McMurtrie HL, Cleary HJ, Alvarez BV, et al. The bicarbonate transport metabolon. J Enzyme Inhib Med Chem. 2004;19:231-236.
23. Bainbridge JW, Stephens C, Parsley K, et al. In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium. Gene Ther. 2001;8:1665-1668.
24. Borras T, Gabelt BT, Klintworth GK, Peterson JC, Kaufman PL. Non-invasive observation of repeated adenoviral GFP gene delivery to the anterior segment of the monkey eye in vivo. J Gene Med. 2001;3:437-449.
25. Challa P, Luna C, Liton PB, et al. Lentiviral mediated gene delivery to the anterior chamber of rodent eyes. Mol Vis. 2005;11:425-430.
26. Barraza RA, Rasmussen CA, Loewen N, et al. Prolonged transgene expression with lentiviral vectors in the aqueous humor outflow pathway of nonhuman primates. Hum Gene Ther. 2009;20:191-200.
27. Sun XC, Bonanno JA, Jelamskii S, Xie Q. Expression and localization of NaHCO3 cotransporter in bovine corneal endothelium. Am J Physiol Cell Physiol. 2000;279:C1648-C1655.
28. Hedbys B, Mishima S. The thickness-hydration relationship of the cornea. Exp Eye Res. 1966;5:221-228.
29. Fatt I, Weissman B. Physiology of the Eye: An Introduction to the Vegetative Functions. Oxford: Butterwort-Heinemann; 1992.
30. Egan CA, Hodge DO, McLaren JW, Bourne WM. Effect of dorzolamide on corneal endothelial function in normal human eyes. Invest Ophthalmol Vis Sci. 1998;39:23-29.
31. Giasson CJ, Nguyen TQ, Boisjoly HM, Lesk MR, Amyot M, Charest M. Dorzolamide and corneal recovery from edema in patients with glaucoma or ocular hypertension. Am J Ophthalmol. 2000;129: 144-150.
32. Kaminski S, Hommer A, Koyuncu D, Biowski R, Barisani T, Baumgartner I. Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility. Acta Ophthalmol Scand. 1998;76:78-79.
33. Georgiadis A, Tschernutter M, Bainbridge JW, et al. AAV-mediated knockdown of Peripherin-2 in vivo using miRNA-based hairpins. Gene Ther. 2010;17:486-493.
34. O'Reilly M, Palfi A, Chadderton N, et al. RNA interference-mediated suppression and replacement of human rhodopsin in vivo. Am J Hum Genet. 2007;81:127-135.
35. Paskowitz DM, Greenberg KP, Yasumura D, et al. Rapid and stable knockdown of an endogenous gene in retinal pigment epithelium. Hum Gene Ther. 2007;18:871-880.
36. Tam LC, Kiang AS, Kennan A, et al. Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10). Hum Mol Genet. 2008;17:2084-2100.
37. Justilien V, Pang JJ, Renganathan K, et al. SOD2 knockdown mouse model of early AMD. Invest Ophthalmol Vis Sci. 2007;48:4407-4420.
38. Gorbatyuk M, Justilien V, Liu J, Hauswirth WW, Lewin AS. Suppression of mouse rhodopsin expression in vivo by AAV mediated siRNA delivery. Vision Res. 2007;47:1202-1208.
39. Loewen N, Fautsch MP, Teo WL, Bahler CK, Johnson DH, Poeschla EM. Long-term, targeted genetic modification of the aqueous humor outflow tract coupled with noninvasive imaging of gene expression in vivo. Invest Ophthalmol Vis Sci. 2004;45:3091-3098.
40. Buie LK, Rasmussen CA, Porterfield EC, et al. Self-complementary AAV virus (scAAV) safe and long-term gene transfer in the trabecular meshwork of living rats and monkeys. Invest Ophthalmol Vis Sci. 51:236-248.
41. Doi K, Hargitai J, Kong J, et al. Lentiviral transduction of green fluorescent protein in retinal epithelium: evidence of rejection. Vision Res. 2002;42:551-558.
42. Doi K, Kong J, Hargitai J, Goff SP, Gouras P. Transient immunosuppression stops rejection of virus-transduced enhanced green fluorescent protein in rabbit retina. J Virol. 2004;78:11327-11333.
43. Brooks AR, Harkins RN, Wang P, Qian HS, Liu P, Rubanyi GM. Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle. J Gene Med. 2004;6:395-404.
44. Abordo-Adesida E, Follenzi A, Barcia C, et al. Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther. 2005; 16:741-751.
45. - cotransporter. J Biol Chem. 2007;282:9042-9052.
46. Domingo Gordo B, Urcelay Segura JL, Conejero Arroyo J, Balado Vazquez P, Rodriguez Ausin P. [Corneal descompensation in patients with endothelial compromise treated with topical dorzolamide]. Arch Soc Esp Oftalmol. 2002;77:139-144.
47. Epstein RJ, Brown SV, Konowal A. Endothelial changes associated with topical dorzolamide do appear to be significant (Letter). Arch Ophthalmol. 2004;122:1089, author reply 1090.
48. Konowal A, Morrison JC, Brown SV, et al. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol. 1999;127:403-406.
49. Tanimura H, Minamoto A, Narai A, Hirayama T, Suzuki M, Mishima HK. Corneal edema in glaucoma patients after the addition of brinzolamide 1% ophthalmic suspension. Jpn J Ophthalmol. 2005; 49:332-333.
50. Wirtitsch MG, Findl O, Kiss B, Petternel V, Heinzl H, Drexler W. Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata. Arch Ophthalmol. 2003; 121:621-625.